Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
44.5M
-
Number of holders
-
43
-
Total 13F shares, excl. options
-
9.75M
-
Shares change
-
+7.41K
-
Total reported value, excl. options
-
$161M
-
Value change
-
+$2.12M
-
Number of buys
-
22
-
Number of sells
-
-26
-
Price
-
$16.54
Significant Holders of TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) as of Q3 2020
56 filings reported holding TELA - TELA Bio, Inc. - Common Stock, par value $0.001 per share as of Q3 2020.
TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) has 43 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.75M shares
of 44.5M outstanding shares and own 21.9% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (3.03M shares), Essex Woodlands Management, Inc. (1.48M shares), RTW INVESTMENTS, LP (1.38M shares), Alyeska Investment Group, L.P. (461K shares), VANGUARD GROUP INC (409K shares), COWEN AND COMPANY, LLC (409K shares), Opaleye Management Inc. (362K shares), SILVERCREST ASSET MANAGEMENT GROUP LLC (319K shares), BlackRock Inc. (294K shares), and PURA VIDA INVESTMENTS, LLC (289K shares).
This table shows the top 43 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.